Barz, M. J., Hof, J., Groeneveld-Krentz, S., Loh, J. W., Szymansky, A., Astrahantseff, K., . . . Kirschner-Schwabe, R. (2020). Subclonal NT5C2 mutations are associated with poor outcomes after relapse of pediatric acute lymphoblastic leukemia. Blood.
Citação norma ChicagoBarz, Malwine J., et al. "Subclonal NT5C2 Mutations Are Associated With Poor Outcomes After Relapse of Pediatric Acute Lymphoblastic Leukemia." Blood 2020.
ציטוט MLABarz, Malwine J., et al. "Subclonal NT5C2 Mutations Are Associated With Poor Outcomes After Relapse of Pediatric Acute Lymphoblastic Leukemia." Blood 2020.
אזהרה: ציטוטים אלה לעיתים לא מדויקים ב 100%.